Animal vaccine researcher Dr Ronald Schultz says, «Few or no scientific studies have demonstrated a need for cats or dogs to be revaccinated.»
Not exact matches
Young sifakas are more likely to get sick, but if
researchers can figure out how older
animals manage to fight the infection, they might be able to develop
vaccines that provide infants the same protection.
Even if
researchers could protect large numbers of Tasmanian devils with a
vaccine that was 100 percent effective, those
animals» immunity would not be passed on to their offspring; any vaccination program would need to go on indefinitely, a formidable challenge.
And in a study of monkeys,
researchers discovered that a cytomegalovirus - based
vaccine protected 50 percent of
animals from infection by simian immunodeficiency virus.
Researchers used IL - 15 to develop a whole tumor cell
vaccine to target breast (TS / A) and prostate (TRAMP - C2) cancer cells in
animal models; results showed that tumor cells stopped growing after the
vaccine was introduced and that beneficial effects were enhanced further when IL - 15Rα was co-produced by the
vaccine cells.
The
researchers noted that the
vaccine also protects the camels from the related virus that causes camelpox, which is similar to smallpox in humans and can be deadly in the
animals.
MERS and SARS: The pause includes three grants and two contracts that are attempting to develop a strain of the MERS coronavirus that sickens mice so that
researchers will have an
animal model for testing MERS drugs and
vaccines.
When the
researchers vaccinated mice with the Dutch
vaccine, the
animals were more vulnerable to strains that had the mutations than to ones that didn't.
With only
animal studies to go on,
researchers also had to pursue a crash course in
vaccine and drug testing to get products into the field
The
researchers will continue to perfect their
vaccine's design and hope to move into more advanced
animal trials soon.
The
researchers administered a potential
vaccine consisting of two components to twelve rhesus monkeys that served as an
animal model for the human HIV infection.
Researchers from The University of Texas Medical Branch at Galveston have developed new potential
vaccines that protect
animals against the bacteria that causes the deadly plague.
Researchers at the University of Maryland and Duke University have designed a novel protein - sugar
vaccine candidate that, in an
animal model, stimulated an immune response against sugars that form a protective shield around HIV.
This week, what the
researchers from NIAID (Nature Medicine) and Scripps / J & J (Science) showed is that experimental
vaccines made from the stem region only can be broadly protective in several
animal models.